期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
MutL homolog 1 germline mutation c.(453+1_454-1)_(545+1_546-1)del identified in lynch syndrome:A case report and review of literature 被引量:1
1
作者 Xi-Wen Zhang zan-hui jia +4 位作者 Li-Ping Zhao Yi-Shi Wu Man-Hua Cui Yan jia Tian-Min Xu 《World Journal of Clinical Cases》 SCIE 2022年第20期7105-7115,共11页
BACKGROUND Lynch syndrome(LS)is an autosomal dominant hereditary disorder because of germline mutations in DNA mismatch repair genes,such as MutL homolog 1(MLH1),PMS1 homolog 2,MutS homolog 2,and MutS homolog 6.Gene m... BACKGROUND Lynch syndrome(LS)is an autosomal dominant hereditary disorder because of germline mutations in DNA mismatch repair genes,such as MutL homolog 1(MLH1),PMS1 homolog 2,MutS homolog 2,and MutS homolog 6.Gene mutations could make individuals and their families more susceptible to experiencing various malignant tumors.In Chinese,MLH1 germline mutation c.(453+1_454-1)_(545+1_546-1)del-related LS has been infrequently reported.Therefore,we report a rare LS patient with colorectal and endometrioid adenocarcinoma and describe her pedigree characteristics.CASE SUMMARY A 57-year-old female patient complained of irregular postmenopausal vaginal bleeding for 6 mo.She was diagnosed with LS,colonic malignancy,endometrioid adenocarcinoma,secondary fallopian tube malignancy,and intermyometrial leiomyomas.Then,she was treated by abdominal hysterectomy,bilateral oviduct oophorectomy,and sentinel lymph node resection.Genetic testing was performed using next-generation sequencing technology to detect the causative genetic mutations.Moreover,all her family members were offered a free genetic test,but no one accepted it.CONCLUSION No tumor relapse or metastasis was found in the patient during the 30-mo followup period.The genetic panel sequencing showed a novel pathogenic germline mutation in MLH1,c.(453+1_454-1)_(545+1_546-1)del,for LS.Moreover,cancer genetic counseling and testing are still in the initial development state in China,and maybe face numerous challenges in the further. 展开更多
关键词 Lynch syndrome Colorectal cancer Endometrial cancer MLH1 gene Gene testing Case report
下载PDF
Overcome cancer drug resistance by targeting epigenetic modifications of centrosome 被引量:1
2
作者 zan-hui jia Xing-Gang Wang Hong Zhang 《Cancer Drug Resistance》 2019年第2期210-224,共15页
The centrosome is an organelle that serves as the microtubule-and actin-organizing center of human cells.Although the centrosome is small of size,it is great important on cellular function that regulates cytoskeletal ... The centrosome is an organelle that serves as the microtubule-and actin-organizing center of human cells.Although the centrosome is small of size,it is great important on cellular function that regulates cytoskeletal organization and governs precise spindle orientation/positioning ensuring equal distribution of cellular components in cell division.Epigenetic modifications to centrosome proteins can lead to centrosome aberrations,such as disorganized spindles and centrosome amplification causing aneuploidy and genomic instability.Epigenetic disturbances are associated not only with carcinogenesis and cancer progression,but also with drug resistance to chemotherapy.In this review,we discuss mechanisms of epigenetic alteration during the centrosome biogenesis in cancer.We provide an update on the current status of clinical trials that aim to target epigenetic modifications in centrosome aberrations and to thwart drug resistance. 展开更多
关键词 CENTROSOME genomic instability epigenetic disturbance CARCINOGENESIS cancer clinical trials
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部